Market capitalization | CHF345.33m |
Enterprise Value | CHF278.58m |
P/E (TTM) P/E ratio | 19.61 |
EV/FCF (TTM) EV/FCF | 9.39 |
EV/Sales (TTM) EV/Sales | 1.82 |
P/S ratio (TTM) P/S ratio | 2.26 |
P/B ratio (TTM) P/B ratio | 2.45 |
Dividend yield | 2.21% |
Last dividend (FY24) | CHF8.20 |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
Jun '24 |
+/-
%
|
||
Revenue | 153 153 |
2%
2%
|
|
Gross Profit | 48 48 |
8%
8%
|
|
EBITDA | 25 25 |
27%
27%
|
EBIT (Operating Income) EBIT | 20 20 |
37%
37%
|
Net Profit | 18 18 |
33%
33%
|
In millions CHF.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. It operates through the following segments: Wound Management, Incontinence Management, Risk Prevention, Disinfection, Personal Healthcare, and Facility Products. The Wound Management segment provides traditional wound treatment; negative pressure wound therapy; as well as compression and support therapy. The Incontinence Management segment offers securing systems; medicinal skin care; including patient and personal hygiene. The Risk Prevention segment provides disposable surgical instruments, surgical clothing, as well as surgical and examination gloves. The Disinfection segment sells hand disinfection, hand protection, and skin disinfection. The Personal Healthcare segment markets plaster and wound dressings; thermometers; and sphygmomanometers. The Facility Products segment supplies hygienic paper, microfiber wipes, and foils products. The company was founded on April 13, 1883 and is headquartered in Neuhausen, Switzerland.
Head office | Switzerland |
CEO | Claus Martini |
Employees | 304 |
Founded | 1883 |
Website | www.ivf.hartmann.info |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.